COVID-19 vaccine claims scheme

29 August 2021: Medicines Australia commends the Australian Government on the COVID-19 Vaccine Claim Scheme for anyone who experiences the very rare, serious side effects from a TGA-approved COVID-19 vaccine.

The announcement of this Scheme is another critical step in Australia’s COVID-19 vaccination program and encouraging a high vaccinated population. The Scheme provides a safety net for those who receive the vaccine and for those who administer it, in the very rare case of a serious adverse side effect. 

From 6 September 2021, Australians will be able to submit intentions to claim, backdated to February 2021. The Scheme will cover verified claims valued above $5,000 by a team of independent experts.

Medicines Australia provided recommendations to the Government last year, which formed part of the extensive consultation between peak medical, healthcare, business and insurance sectors.

“Australians have truly shown the values of selflessness and mateship as they have rolled up their sleeves in large numbers and received a vaccination against this deadly virus,” said Medicines Australia CEO Elizabeth de Somer.

“If someone does experience an adverse side effect from a vaccination, these are normally short-term. But in the rare case that the effects are moderate or serious, Australians now have the option to seek compensation.”

“All parties who have been involved in the research, development, manufacturing and deployment of these COVID-19 vaccines have moved mountains to deliver safe, effective and quality vaccines. As well as shielding the employees and medical professionals who administer the vaccine, it is important that appropriate protection should also be extended to the manufacturers, distributors, or other entities who are involved in the development or deployment of the COVID-19 vaccine.”

The COVID-19 Vaccine Claim Scheme will play an effective role in enhancing national and global vaccination efforts so we can begin to recover from this pandemic. We look forward to further collaborating with the Australian Government and industry to advance our shared public health goals and ensure no Australian is left behind.

For further information or media interviews with CEO Elizabeth de Somer, please contact:
Chrystianna Moran – 0424 995 118 /